AETHLON MEDICAL INC (AEMD)
$6.57+$5.18 (+362.24%) Latest session
Latest AEMD Insider Trades
Chetan Shah - DirectorTax withholding / forfeiture$2K
Chetan Shah - DirectorChetan Shah - DirectorChetan Shah - DirectorAethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 3 | 5,455 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
24 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 2,182 | $4.10 | $2K | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 2,182 | $4.10 | $2K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 1,091 | $4.10 | $895 | |
| Angela Rossetti - Director | Grant or award | Common Stock | 21,815 | $11.45 | $50K | |
| Chetan Shah - Director | Grant or award | Common Stock | 21,815 | $11.45 | $50K | |
| Edward G. Broenniman - Director | Grant or award | Common Stock | 21,815 | $11.45 | $50K | |
| Nicolas Gikakis - Director | Grant or award | Common Stock | 21,815 | $11.45 | $50K | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 178 | $10.95 | $390 | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 178 | $10.95 | $390 | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 89 | $10.95 | $195 | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 179 | $13.85 | $496 | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 179 | $13.85 | $496 | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 89 | $13.85 | $247 | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 893 | $37.45 | $669 | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $37.45 | $1K | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $37.45 | $1K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 893 | $60.00 | $1K | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $60.00 | $2K | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 1,786 | $60.00 | $2K | |
| Edward G. Broenniman - Director | Grant or award | Common Stock | 142,857 | $140.00 | $50K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 1,645 | $143.20 | $589 | |
| Chetan Shah - Director | Tax withholding / forfeiture | Common Stock | 3,289 | $186.40 | $2K | |
| Nicolas Gikakis - Director | Tax withholding / forfeiture | Common Stock | 3,289 | $186.40 | $2K | |
| Edward G. Broenniman - Director | Tax withholding / forfeiture | Common Stock | 1,645 | $186.40 | $767 |
AETHLON MEDICAL INC (AEMD) had 3 insider filings in the last 90 days, with the most recent on 2026-07-01. The full record for AEMD runs to 24 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AEMD were filed in the last 90 days.
No insider sales of AEMD were filed in the last 90 days.
This page tracks AEMD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AEMD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
